INVITROCUE LIMITED - Announcements

Currently unlisted. Add to my watchlist

Invitrocue Limited is engaged in research and experimental development on biotechnology,... Invitrocue Limited is engaged in research and experimental development on biotechnology, life and medical science. The Company offers a three dimension (3D) cell-based scaffolding technology, which mimics a human for Tropical Diseases to investigate the lifecycle of Plasmodium cynomolgi (monkey malaria) and helps in evaluating new drug targets to malaria infection using in vitro hepatocyte culture systems. It is engaged in developing non-small cell lung cancer organoids and for drug testing programs using approved drugs. It is also engaged in range of activities, including in vitro cell-based assays, patient-derived organoids, digital pathology and medical imaging, while providing access to industry networks. It also offers an in vitro screening of experimental drug compounds for anti-leishmanial activity. It intends to develop an in vitro 3D perfused liver model to expedite and facilitate new application notes in infectious liver diseases.More

Announcements

Filter Results

All Price Sensitive Only

IVQ	Annual Report to shareholders		28/09/18	3.43MB	Share
IVQ	Ceasing to be a substantial holder		10/09/18	859.31KB	Share
IVQ	Business updates		04/09/18	601.59KB	Share
IVQ	Preliminary Final Report	PRICE SENSITIVE	31/08/18	863.75KB	Share
IVQ	Change in substantial holding		28/08/18	1.11MB	Share
IVQ	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/18	697.91KB	Share
IVQ	Expiry of Unlisted Warrants		17/07/18	322.17KB	Share
IVQ	Expiry of Unlisted Warrants		02/07/18	321.7KB	Share
IVQ	Cleansing statement		28/06/18	328.21KB	Share
IVQ	Appendix 3B		28/06/18	740.41KB	Share
IVQ	Proposed issue of securities		26/06/18	230.69KB	Share
IVQ	Change in substantial holding		25/05/18	1.07MB	Share
IVQ	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/18	347.69KB	Share
IVQ	Appendix 4G		27/04/18	249.85KB	Share
IVQ	IVQ launches Personalised Cancer Screening Service Onco-PDO	PRICE SENSITIVE	13/04/18	461.01KB	Share
IVQ	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/18	1.2MB	Share
IVQ	Grant from Northern Ireland to commercialize Onco-PDO	PRICE SENSITIVE	26/02/18	458.63KB	Share
IVQ	Investor presentation		23/02/18	2.47MB	Share
IVQ	Change of Director's Interest Notice - Jamie Khoo		20/02/18	255.37KB	Share
IVQ	Change of Director's Interest Notice - Steven Fang		20/02/18	254.97KB	Share
IVQ	Change of Director's Interest Notice - Hanry Yu		20/02/18	255.83KB	Share
IVQ	Change of Director's Interest Notice		14/02/18	254.08KB	Share
IVQ	Change of Director's Interest Notice		14/02/18	254.06KB	Share
IVQ	Change of Director's Interest Notice		14/02/18	254.23KB	Share
IVQ	Change of Director's Interest Notice		14/02/18	255.6KB	Share
IVQ	Change of Director's Interest Notice		14/02/18	254.84KB	Share
IVQ	Initial Director's Interest Notice		12/02/18	245.1KB	Share
IVQ	Appendix 3B		09/02/18	739.88KB	Share
IVQ	Appointment of non-executive director		07/02/18	449.25KB	Share
IVQ	Appendix 4C & quarterly business update	PRICE SENSITIVE	31/01/18	1021.05KB	Share
IVQ	Appendix 3B		29/01/18	732.5KB	Share
IVQ	IVQ successfully grows liver cancer organoids	PRICE SENSITIVE	18/01/18	249.24KB	Share
IVQ	Escrow release		15/01/18	341.65KB	Share
IVQ	Cleansing statement		08/12/17	295.16KB	Share
IVQ	Appendix 3B		08/12/17	740.2KB	Share
IVQ	Proposed issue of securities		07/12/17	296.43KB	Share
IVQ	Results of Meeting		30/11/17	365.8KB	Share
IVQ	2017 AGM Presentation		30/11/17	2.58MB	Share
IVQ	Cleansing statement		13/11/17	295.34KB	Share
IVQ	Appendix 3B		13/11/17	743.49KB	Share
IVQ	Proposed issue of securities	PRICE SENSITIVE	10/11/17	196.71KB	Share
IVQ	Business updates		31/10/17	329.78KB	Share
IVQ	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/17	280.82KB	Share
IVQ	Notice of Annual General Meeting/Proxy Form		30/10/17	728.09KB	Share
IVQ	Annual Report to shareholders		29/09/17	1.66MB	Share
IVQ	Appointments to management team		28/09/17	473.11KB	Share
IVQ	Preliminary Final Report	PRICE SENSITIVE	31/08/17	787.92KB	Share
IVQ	IVQ receives award from Singapore government IP office	PRICE SENSITIVE	29/08/17	448.01KB	Share
IVQ	Investor Presentation		23/08/17	1.25MB	Share
IVQ	Appendix 4C quarterly and Business Update	PRICE SENSITIVE	31/07/17	743.79KB	Share
IVQ	Establishment of joint lab with Genome Institute Singapore	PRICE SENSITIVE	20/07/17	463.99KB	Share
IVQ	Updates to IVQ's collaboration with the Garvan Institute	PRICE SENSITIVE	03/07/17	569.79KB	Share
IVQ	Cleansing Statement		30/06/17	295.25KB	Share
IVQ	Appendix 3B		30/06/17	732.76KB	Share
IVQ	Proposed issue of securities	PRICE SENSITIVE	29/06/17	197.33KB	Share
IVQ	Corporate Governance Statement		24/05/17	158.67KB	Share
IVQ	IVQ expands into in-vitro skin and wound healing assays	PRICE SENSITIVE	22/05/17	300.92KB	Share
IVQ	Response to ASX Appendix 4C Query	PRICE SENSITIVE	11/05/17	716.19KB	Share
IVQ	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/17	279.48KB	Share
IVQ	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/17	285.33KB	Share
IVQ	Collaboration with the Garvan Institute of Medical Research	PRICE SENSITIVE	23/02/17	297.1KB	Share
IVQ	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/17	698.67KB	Share
IVQ	Escrow release		03/01/17	334.52KB	Share
IVQ	Results of Meeting		30/11/16	356.9KB	Share
IVQ	Dr. Ramanuj DasGupta to join as Senior Scientific Director		24/11/16	295.04KB	Share
IVQ	Change of Address		22/11/16	170.12KB	Share
IVQ	Appendix 4C - quarterly-IVQ.AX	PRICE SENSITIVE	31/10/16	278.76KB	Share
IVQ	Notice of Annual General Meeting/Proxy Form-IVQ.AX		28/10/16	707.94KB	Share
IVQ	Research Collaboration with Genome Institute of Singapore-IVQ.AX	PRICE SENSITIVE	24/10/16	303.6KB	Share
IVQ	Annual Report to shareholders-IVQ.AX		30/09/16	1.77MB	Share
IVQ	Appendix 4G-IVQ.AX		30/09/16	259.55KB	Share
IVQ	Addendum to Preliminary Final Report-IVQ.AX	PRICE SENSITIVE	08/09/16	230.62KB	Share
IVQ	*IVQ Awarded Singapore's ASTAR Tender-IVQ.AX**	PRICE SENSITIVE	05/09/16	228.47KB	Share
IVQ	Preliminary Final Report-IVQ.AX	PRICE SENSITIVE	31/08/16	732.84KB	Share
IVQ	Appendix 3B-IVQ.AX		30/08/16	771.15KB	Share
IVQ	IVQ signs strategic partnership agreement with QIAGEN Suzhou-IVQ.AX	PRICE SENSITIVE	22/08/16	319.62KB	Share
IVQ	Escrow release-IVQ.AX		16/08/16	212.06KB	Share
IVQ	IVQ announces new program focused on Hepatitis B virus-IVQ.AX	PRICE SENSITIVE	28/07/16	229.66KB	Share
IVQ	Appendix 4C - quarterly-IVQ.AX	PRICE SENSITIVE	28/07/16	503.54KB	Share
IVQ	IVQ commences Pancreatic Toxicity Assay development-IVQ.AX	PRICE SENSITIVE	12/07/16	240.39KB	Share
IVQ	Change of auditor-IVQ.AX		07/07/16	120.1KB	Share
IVQ	IVQ publishes Human Stem Cell Derived Hepatocytes results-IVQ.AX		24/05/16	230.38KB	Share
IVQ	IVQ Convenes Scientific and Medical Advisory Board-IVQ.AX		20/05/16	192.01KB	Share
IVQ	Investor Presentation-IVQ.AX		16/05/16	7.45MB	Share
IVQ	IVQ Announces Malaria Initiative-IVQ.AX	PRICE SENSITIVE	16/05/16	173.3KB	Share
IVQ	IVQ Expands 3D Cell-based Platform for Oncology-IVQ.AX	PRICE SENSITIVE	12/05/16	65.33KB	Share
IVQ	Appendix 4C - quarterly-IVQ.AX	PRICE SENSITIVE	27/04/16	423.55KB	Share
IVQ	Appendix 3B (Revised)		30/03/16	875.99KB	Share
IVQ	Initial Director's Interest Notice		24/03/16	199.12KB	Share
IVQ	Director Appointment		24/03/16	182.21KB	Share
IVQ	Appendix 3B		23/03/16	614.26KB	Share
IVQ	Becoming a substantial holder - Steven Fang		15/03/16	178.45KB	Share
IVQ	Agreement with London School of Hygiene & Tropical Medicine	PRICE SENSITIVE	09/03/16	167.18KB	Share
IVQ	Operations update	PRICE SENSITIVE	07/03/16	157.52KB	Share
IVQ	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/16	344.76KB	Share
IVQ	Operations update	PRICE SENSITIVE	16/02/16	566.57KB	Share
IVQ	Investor presentation		15/02/16	902.13KB	Share
IVQ	Operations update	PRICE SENSITIVE	08/02/16	173.67KB	Share
IVQ	Becoming a substantial holder - Clearbridge Accelerator		02/02/16	146.48KB	Share
IVQ	Becoming a substantial holder		02/02/16	734.56KB	Share

IVQ Annual Report to shareholders
28/09/18		3.43MB	Share
IVQ Ceasing to be a substantial holder
10/09/18		859.31KB	Share
IVQ Business updates
04/09/18		601.59KB	Share
IVQ Preliminary Final Report
31/08/18	PRICE SENSITIVE	863.75KB	Share
IVQ Change in substantial holding
28/08/18		1.11MB	Share
IVQ Appendix 4C - quarterly
31/07/18	PRICE SENSITIVE	697.91KB	Share
IVQ Expiry of Unlisted Warrants
17/07/18		322.17KB	Share
IVQ Expiry of Unlisted Warrants
02/07/18		321.7KB	Share
IVQ Cleansing statement
28/06/18		328.21KB	Share
IVQ Appendix 3B
28/06/18		740.41KB	Share
IVQ Proposed issue of securities
26/06/18		230.69KB	Share
IVQ Change in substantial holding
25/05/18		1.07MB	Share
IVQ Appendix 4C - quarterly
30/04/18	PRICE SENSITIVE	347.69KB	Share
IVQ Appendix 4G
27/04/18		249.85KB	Share
IVQ IVQ launches Personalised Cancer Screening Service Onco-PDO
13/04/18	PRICE SENSITIVE	461.01KB	Share
IVQ Half Yearly Report and Accounts
28/02/18	PRICE SENSITIVE	1.2MB	Share
IVQ Grant from Northern Ireland to commercialize Onco-PDO
26/02/18	PRICE SENSITIVE	458.63KB	Share
IVQ Investor presentation
23/02/18		2.47MB	Share
IVQ Change of Director's Interest Notice - Jamie Khoo
20/02/18		255.37KB	Share
IVQ Change of Director's Interest Notice - Steven Fang
20/02/18		254.97KB	Share
IVQ Change of Director's Interest Notice - Hanry Yu
20/02/18		255.83KB	Share
IVQ Change of Director's Interest Notice
14/02/18		254.08KB	Share
IVQ Change of Director's Interest Notice
14/02/18		254.06KB	Share
IVQ Change of Director's Interest Notice
14/02/18		254.23KB	Share
IVQ Change of Director's Interest Notice
14/02/18		255.6KB	Share
IVQ Change of Director's Interest Notice
14/02/18		254.84KB	Share
IVQ Initial Director's Interest Notice
12/02/18		245.1KB	Share
IVQ Appendix 3B
09/02/18		739.88KB	Share
IVQ Appointment of non-executive director
07/02/18		449.25KB	Share
IVQ Appendix 4C & quarterly business update
31/01/18	PRICE SENSITIVE	1021.05KB	Share
IVQ Appendix 3B
29/01/18		732.5KB	Share
IVQ IVQ successfully grows liver cancer organoids
18/01/18	PRICE SENSITIVE	249.24KB	Share
IVQ Escrow release
15/01/18		341.65KB	Share
IVQ Cleansing statement
08/12/17		295.16KB	Share
IVQ Appendix 3B
08/12/17		740.2KB	Share
IVQ Proposed issue of securities
07/12/17		296.43KB	Share
IVQ Results of Meeting
30/11/17		365.8KB	Share
IVQ 2017 AGM Presentation
30/11/17		2.58MB	Share
IVQ Cleansing statement
13/11/17		295.34KB	Share
IVQ Appendix 3B
13/11/17		743.49KB	Share
IVQ Proposed issue of securities
10/11/17	PRICE SENSITIVE	196.71KB	Share
IVQ Business updates
31/10/17		329.78KB	Share
IVQ Appendix 4C - quarterly
30/10/17	PRICE SENSITIVE	280.82KB	Share
IVQ Notice of Annual General Meeting/Proxy Form
30/10/17		728.09KB	Share
IVQ Annual Report to shareholders
29/09/17		1.66MB	Share
IVQ Appointments to management team
28/09/17		473.11KB	Share
IVQ Preliminary Final Report
31/08/17	PRICE SENSITIVE	787.92KB	Share
IVQ IVQ receives award from Singapore government IP office
29/08/17	PRICE SENSITIVE	448.01KB	Share
IVQ Investor Presentation
23/08/17		1.25MB	Share
IVQ Appendix 4C quarterly and Business Update
31/07/17	PRICE SENSITIVE	743.79KB	Share
IVQ Establishment of joint lab with Genome Institute Singapore
20/07/17	PRICE SENSITIVE	463.99KB	Share
IVQ Updates to IVQ's collaboration with the Garvan Institute
03/07/17	PRICE SENSITIVE	569.79KB	Share
IVQ Cleansing Statement
30/06/17		295.25KB	Share
IVQ Appendix 3B
30/06/17		732.76KB	Share
IVQ Proposed issue of securities
29/06/17	PRICE SENSITIVE	197.33KB	Share
IVQ Corporate Governance Statement
24/05/17		158.67KB	Share
IVQ IVQ expands into in-vitro skin and wound healing assays
22/05/17	PRICE SENSITIVE	300.92KB	Share
IVQ Response to ASX Appendix 4C Query
11/05/17	PRICE SENSITIVE	716.19KB	Share
IVQ Appendix 4C - quarterly
28/04/17	PRICE SENSITIVE	279.48KB	Share
IVQ Half Yearly Report and Accounts
28/02/17	PRICE SENSITIVE	285.33KB	Share
IVQ Collaboration with the Garvan Institute of Medical Research
23/02/17	PRICE SENSITIVE	297.1KB	Share
IVQ Appendix 4C - quarterly
30/01/17	PRICE SENSITIVE	698.67KB	Share
IVQ Escrow release
03/01/17		334.52KB	Share
IVQ Results of Meeting
30/11/16		356.9KB	Share
IVQ Dr. Ramanuj DasGupta to join as Senior Scientific Director
24/11/16		295.04KB	Share
IVQ Change of Address
22/11/16		170.12KB	Share
IVQ Appendix 4C - quarterly-IVQ.AX
31/10/16	PRICE SENSITIVE	278.76KB	Share
IVQ Notice of Annual General Meeting/Proxy Form-IVQ.AX
28/10/16		707.94KB	Share
IVQ Research Collaboration with Genome Institute of Singapore-IVQ.AX
24/10/16	PRICE SENSITIVE	303.6KB	Share
IVQ Annual Report to shareholders-IVQ.AX
30/09/16		1.77MB	Share
IVQ Appendix 4G-IVQ.AX
30/09/16		259.55KB	Share
IVQ Addendum to Preliminary Final Report-IVQ.AX
08/09/16	PRICE SENSITIVE	230.62KB	Share
IVQ *IVQ Awarded Singapore's ASTAR Tender-IVQ.AX**
05/09/16	PRICE SENSITIVE	228.47KB	Share
IVQ Preliminary Final Report-IVQ.AX
31/08/16	PRICE SENSITIVE	732.84KB	Share
IVQ Appendix 3B-IVQ.AX
30/08/16		771.15KB	Share
IVQ IVQ signs strategic partnership agreement with QIAGEN Suzhou-IVQ.AX
22/08/16	PRICE SENSITIVE	319.62KB	Share
IVQ Escrow release-IVQ.AX
16/08/16		212.06KB	Share
IVQ IVQ announces new program focused on Hepatitis B virus-IVQ.AX
28/07/16	PRICE SENSITIVE	229.66KB	Share
IVQ Appendix 4C - quarterly-IVQ.AX
28/07/16	PRICE SENSITIVE	503.54KB	Share
IVQ IVQ commences Pancreatic Toxicity Assay development-IVQ.AX
12/07/16	PRICE SENSITIVE	240.39KB	Share
IVQ Change of auditor-IVQ.AX
07/07/16		120.1KB	Share
IVQ IVQ publishes Human Stem Cell Derived Hepatocytes results-IVQ.AX
24/05/16		230.38KB	Share
IVQ IVQ Convenes Scientific and Medical Advisory Board-IVQ.AX
20/05/16		192.01KB	Share
IVQ Investor Presentation-IVQ.AX
16/05/16		7.45MB	Share
IVQ IVQ Announces Malaria Initiative-IVQ.AX
16/05/16	PRICE SENSITIVE	173.3KB	Share
IVQ IVQ Expands 3D Cell-based Platform for Oncology-IVQ.AX
12/05/16	PRICE SENSITIVE	65.33KB	Share
IVQ Appendix 4C - quarterly-IVQ.AX
27/04/16	PRICE SENSITIVE	423.55KB	Share
IVQ Appendix 3B (Revised)
30/03/16		875.99KB	Share
IVQ Initial Director's Interest Notice
24/03/16		199.12KB	Share
IVQ Director Appointment
24/03/16		182.21KB	Share
IVQ Appendix 3B
23/03/16		614.26KB	Share
IVQ Becoming a substantial holder - Steven Fang
15/03/16		178.45KB	Share
IVQ Agreement with London School of Hygiene & Tropical Medicine
09/03/16	PRICE SENSITIVE	167.18KB	Share
IVQ Operations update
07/03/16	PRICE SENSITIVE	157.52KB	Share
IVQ Half Yearly Report and Accounts
29/02/16	PRICE SENSITIVE	344.76KB	Share
IVQ Operations update
16/02/16	PRICE SENSITIVE	566.57KB	Share
IVQ Investor presentation
15/02/16		902.13KB	Share
IVQ Operations update
08/02/16	PRICE SENSITIVE	173.67KB	Share
IVQ Becoming a substantial holder - Clearbridge Accelerator
02/02/16		146.48KB	Share
IVQ Becoming a substantial holder
02/02/16		734.56KB	Share

REFRESH

First

INVITROCUE LIMITED - Announcements

Announcements

Top Stories